Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income and Growth VCT 2 Regulatory News (MIG2)

Share Price Information for Maven Income and Growth VCT 2 (MIG2)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
MIG2 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income and Growth VCT 2 Share Chart

Interim Management Statement

14 Dec 2012 15:29

RNS Number : 6106T
Maven Income and Growth VCT 2 PLC
14 December 2012
 



Interim Management Statement

 

Maven Income and Growth VCT 2 PLC (the Company) - quarter ended 31 October 2012

 

This Interim Management Statement, for the quarter ended 31 October 2012, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 November 2012 to the date of issue. This Statement has been prepared solely to provide information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1. Financial highlights

 

·; Net asset value (NAV)* of 59.4p at 31 October 2012, compared to 59.7p on 31 July 2012;

·; Total of 150,000 Ordinary Shares bought back for cancellation; and

·; Interim dividend of 1.75p per Ordinary Share paid on 9 November 2012 to Shareholders on the register at close of business on 12 October 2012.

 

\* The NAV at 31 October 2012 is unaudited, includes the value of the interim dividend and reflects the closing bid price of quoted securities as at that date. Unlisted companies are normally valued on a six-monthly basis; the NAV incorporates the Directors' valuation of unlisted investments as at 31 July 2012, adjusted for subsequent events where appropriate.

 

2. Investments and disposals

 

During the quarter ended 31 October 2012, additional funding of £52,799 was provided to two existing unlisted portfolio companies. In the same period cash of £499,639 was raised from the sale of treasury bills; and the receipt of deferred consideration from, and the partial disposals of, one quoted and six unlisted investments generated aggregate proceeds of £345,803 against a total cost of £311,078.

 

In addition, two unlisted portfolio companies were struck off the Register during the period but this had no impact on the Company's NAV as a full provision against the cost of each holding had been made in prior years.

 

3. Recent developments

 

Between 31 October 2012 and the date of this statement, additional funding of £97,429 was provided to an existing unlisted portfolio company; £503,880 of capital was returned by three unlisted companies and the disposal of the unlisted investment in Oliver Kay Holdings generated proceeds of £750,557 and a realised gain of £311,383 over cost. Following these transactions, £999,326 was invested in UK Treasury Bills.

 

Other than as described above and the impact of movements related to the prices of shares in quoted securities, the Board is not aware of any material events during the period from 1 August 2012 to 31 October 2012, or in the period from 1 November 2012 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

14 December 2012

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMMMZKDNGZZM
Date   Source Headline
4th Oct 20132:32 pmRNSTransaction in Own Shares
2nd Oct 20134:03 pmRNSTransaction in Own Shares
2nd Oct 20137:00 amRNSDirector/PDMR Shareholding
27th Sep 201310:09 amRNSHalf Yearly Report
25th Sep 201311:24 amRNSStatement re Proposed Joint Fund Raising
26th Jun 20134:35 pmRNSTransaction in Own Shares
24th Jun 20132:55 pmRNSTransaction in Own Shares
20th Jun 20135:02 pmRNSTransaction in Own Shares
19th Jun 20134:10 pmRNSTransaction in Own Shares
18th Jun 20132:20 pmRNSChange of Registered Office
13th Jun 20133:55 pmRNSInterim Management Statement
11th Jun 20131:45 pmRNSResult of AGM
3rd May 20132:35 pmRNSAnnual Financial Report
30th Apr 20133:01 pmRNSTransaction in Own Shares
26th Apr 20133:01 pmRNSTransaction in Own Shares
26th Apr 20132:56 pmRNSIssue of Equity
24th Apr 20135:06 pmRNSTransaction in Own Shares
22nd Apr 20132:17 pmRNSTransaction in Own Shares
19th Apr 20133:35 pmRNSTransaction in Own Shares
16th Apr 20134:10 pmRNSDirector/PDMR Shareholding
15th Apr 20134:05 pmRNSDirector/PDMR Shareholding
15th Apr 20134:03 pmRNSDirector/PDMR Shareholding
15th Apr 20134:01 pmRNSDirector/PDMR Shareholding
12th Apr 201312:37 pmRNSTransaction in Own Shares
8th Apr 20137:00 amRNSIssue of Equity
5th Apr 20136:08 pmRNSIssue of Equity
28th Mar 20134:18 pmRNSNet Asset Value and Proposed Final Dividend
5th Mar 20134:12 pmRNSIssue of Equity
11th Feb 20135:42 pmRNSOffer for Subscription - Update
23rd Jan 20134:59 pmRNSIssue of Equity
21st Dec 20122:28 pmRNSTransaction in Own Shares
20th Dec 20123:03 pmRNSTransaction in Own Shares
14th Dec 20123:29 pmRNSInterim Management Statement
8th Oct 20124:29 pmRNSTransaction in Own Shares
2nd Oct 201212:42 pmRNSTransaction in Own Shares
1st Oct 20123:21 pmRNSTransaction in Own Shares
28th Sep 20122:38 pmRNSHalf Yearly Report
20th Aug 20122:34 pmRNSDirector/PDMR Shareholding
10th Jul 20121:01 pmRNSTransaction in Own Shares
9th Jul 20125:12 pmRNSTransaction in Own Shares
5th Jul 20123:46 pmRNSTransaction in Own Shares
4th Jul 20123:05 pmRNSTransaction in Own Shares
3rd Jul 20123:16 pmRNSTransaction in Own Shares
2nd Jul 20121:19 pmRNSTransaction in Own Shares
29th Jun 20124:11 pmRNSTransaction in Own Shares
28th Jun 20124:24 pmRNSTransaction in Own Shares
25th Jun 20123:33 pmRNSTransaction in Own Shares
22nd Jun 20122:43 pmRNSTransaction in Own Shares
21st Jun 201211:14 amRNSTransaction in Own Shares
19th Jun 20124:51 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.